Stock Analysts’ upgrades for Friday, June 3rd: C3.ai (NYSE:AI) was upgraded by analysts at StockNews.com to a sell rating. Actinium Pharmaceuticals (NYSE:ATNM) was upgraded by analysts at StockNews.com from a sell rating to a hold rating. American Axle & Manufacturing (NYSE:AXL) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. […]
eFFECTOR Therapeutics (NASDAQ:EFTR – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Friday, Zacks.com reports. The firm currently has a $2.25 target price on the stock. Zacks Investment Research‘s price objective indicates a potential upside of 25.70% from the company’s current […]
Analysts’ downgrades for Thursday, June 2nd: Associated Capital Group (NYSE:AC) was downgraded by analysts at StockNews.com from a hold rating to a sell rating. CMC Materials (NASDAQ:CCMP) was downgraded by analysts at StockNews.com from a buy rating to a hold rating. Comcast (NASDAQ:CMCSA) was downgraded by analysts at StockNews.com from a strong-buy rating to a […]
eFFECTOR Therapeutics (NASDAQ:EFTR – Get Rating)‘s stock had its “buy” rating reiterated by equities research analysts at JMP Securities in a research report issued to clients and investors on Monday, TipRanks reports. They presently have a $8.00 target price on the stock. JMP Securities’ price target indicates a potential upside of 64.61% from the company’s […]
eFFECTOR Therapeutics (NASDAQ:EFTR – Get Rating) released its quarterly earnings results on Wednesday. The company reported $0.44 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.24) by $0.68, MarketWatch Earnings reports. NASDAQ:EFTR traded up $0.07 during mid-day trading on Thursday, hitting $4.14. The company’s stock had a trading volume […]